Bristol-Myers Squibb Co. (BMY) Tops Q2 EPS by 4c
Tweet
Share
E-mailGet Alerts BMY Hot Sheet
Price: $63.33 -0.42%
EPS Growth %: +5.5%
Financial Fact:
Dividends declared per common share: 0.38
Today's EPS Names:
ALZN, ASPU, USAU, More
EPS Growth %: +5.5%
Financial Fact:
Dividends declared per common share: 0.38
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Bristol-Myers Squibb Co. (NYSE: BMY) reported Q2 EPS of $0.48, $0.04 better than the analyst estimate of $0.44. Revenue for the quarter came in at $3.89 billion versus the consensus estimate of $3.85 billion.
Bristol-Myers Squibb Co. reaffirmed FY2014 guidance.
For earnings history and earnings-related data on Bristol-Myers Squibb Co. (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UBS sees a negative catalyst ahead for Nike: Here’s what to watch
- Copart launches $10.50-per-share tender offer to acquire ACV
- Analysts eye Intuit investor day for signs estimates have troughed
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
